Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy
Cardiales Natrium-Glukose-Cotransporter-1 (SGLT1) trägt in einem Mausmodell der diabetischen Kardiomyopathie zur Herzinsuffizienz bei
Basic Research in Cardiology · 11.09.2025 · 120 (6) · 1193-1207
DOI: 10.1007/s00395-025-01136-7 ↗Auf einen Blick
In einem Mausmodell war ein kardialer SGLT1-Knockdown mit weniger Kardiomyopathie nach fettreicher Diät verbunden. Die Autor:innen beschreiben geringere Hypertrophie, Dysfunktion, Fibrose und ROS-Bildung.
Fragestellung
Welche Mechanismen erklären, wie kardiales SGLT1 in Diabetes, Adipositas und Insulinresistenz zur Pathophysiologie der Herzinsuffizienz beiträgt?
Methode
Transgene Mäuse mit kardiomyozytenspezifischem SGLT1-Knockdown und Wildtyp-Littermates; Induktion von Adipositas und Insulinresistenz durch fettreiche Diät von 8–28 Wochen.
Ergebnisse
Nach fettreicher Diät stiegen Körpergewicht und Blutzucker in beiden Gruppen ähnlich an. TG SGLT1-DOWN-Mäuse zeigten dennoch weniger Hypertrophie, systolische und diastolische Dysfunktion, Fibrose, Nox2-Aktivierung und ROS-Produktion.
Schlussfolgerung der Autor:innen
SGLT1 könnte über ROS-Stimulation zur kardialen Schädigung bei Adipositas und Insulinresistenz beitragen und ein therapeutisches Ziel sein, um diabetische Kardiomyopathie zu verhindern oder rückgängig zu machen.
Kernaussagen
- SGLT1-Knockdown milderte die Kardiomyopathie im Mausmodell
- Weniger Hypertrophie, Dysfunktion, Fibrose und ROS-Bildung
- SGLT1 könnte ein therapeutisches Ziel bei diabetischer Kardiomyopathie sein
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 11.09.2025. Verfasst von Zhao Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine and Abboud Cardiovascular Research Center, Universit…. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Heart Failure, Myocytes, Cardiac, Sodium-Glucose Transporter 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association, NHLBI.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Diabetes mellitus can lead to a cardiomyopathy independent of other risk factors such as coronary artery disease and hypertension, in up to 75% of patients. The prevalence of diabetic cardiomyopathy in the population is 1.1%. We previously showed that SGLT1 is expressed in cardiomyocytes and is further upregulated in diabetic cardiomyopathy and other forms of heart failure. In this study, we sought to determine the mechanisms by which cardiac SGLT1 contributes to the pathophysiology of heart failure in diabetes, obesity, and insulin resistance. We determined whether transgenic mice with cardiomyocyte-specific knockdown of SGLT1 (TG SGLT1-DOWN ) had attenuation of cardiomyopathy after induction of obesity and insulin resistance by exposure to a high fat diet (HFD) from ages 8–28 weeks. TG SGLT1-DOWN mice and wildtype (WT) littermates exhibited similar increases in body weight and blood glucose after exposure to HFD. Nevertheless, TG SGLT1-DOWN mice exhibited attenuation of cardiomyopathy, manifested by less hypertrophy, systolic and diastolic dysfunction, fibrosis, nicotinamide adenine dinucleotide phosphate oxidase 2 (Nox2) activation, and reactive oxygen species (ROS) production. In vivo hyperinsulinemia and in vitro exposure of cardiomyocytes to high glucose or insulin led to an increase in SGLT1 expression by increasing binding of the transcription factors HNF-1 and Sp1 to the SGLT1 gene ( Slc5a1 ), and the transcript stabilizer HuR to SGLT1 mRNA. SGLT1 may contribute to cardiac injury in obesity and insulin resistance by stimulating ROS through its interaction with EGFR. SGLT1 may represent a therapeutic target for inhibition to prevent or to reverse diabetic cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine and Abboud Cardiovascular Research Center, University of Iowa, 25 South Grand Avenue, 1191D ML, Iowa City, IA, 52242, USA.
- Department of Pharmaceutical Sciences, University of St. Joseph, West Hartford, CT, USA.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Carver College of Medicine and Abboud Cardiovascular Research Center, University of Iowa, Iowa City, IA, USA.
- Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine and Abboud Cardiovascular Research Center, University of Iowa, 25 South Grand Avenue, 1191D ML, Iowa City, IA, 52242, USA.…
- Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA, USA. ferhaan-ahmad@uiowa.edu.
ORCID-Profile: Ferhaan Ahmad
Förderung
- NHLBI NIH HHS
- American Heart Association
- NHLBI
Zitieren
APA
Li, Z., Freiberg, S., Music, M. L., Gu, L., Nacos, S., Phillips, J. P., Hassan, A., Shibbani, K., Munir, S. S., Kumar, V. K., Halligan, L., Michel, M. E., London, B. F., Bui, N., Cicha, M., Buffard, V., Abel, E. D., & Ahmad, F. (2025). Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy. Basic Research in Cardiology, 120(6), 1193-1207. https://doi.org/10.1007/s00395-025-01136-7
Vancouver
Li Z, Freiberg S, Music ML, Gu L, Nacos S, Phillips JP, et al. Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy. Basic Research in Cardiology. 2025;120(6):1193-1207. doi:10.1007/s00395-025-01136-7
BibTeX
@article{Li2025,
author = {Li, Zhao and Freiberg, Sydney and Music, Meredith L and Gu, Lina and Nacos, Sarah and Phillips, Joseph P and Hassan, Adil and Shibbani, Kamel and Munir, Sanah S and Kumar, Vooha K and Halligan, Luke and Michel, Mia E and London, Benjamin F and Bui, Ngan and Cicha, Michael and Buffard, Valerie and Abel, E Dale and Ahmad, Ferhaan},
title = {Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy},
journal = {Basic Research in Cardiology},
year = {2025},
volume = {120},
number = {6},
pages = {1193--1207},
doi = {10.1007/s00395-025-01136-7}
}
EUVIMED